Acadian Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$111K Sell
3,167
-8,527
-73% -$336K ﹤0.01% 1720
2026
Q2
$540K Buy
+11,694
New +$421K ﹤0.01% 1426
2024
Q4
– Sell
-4,744
Closed -$274K – 2235
2024
Q3
$274K Buy
+4,744
New +$233K ﹤0.01% 1262
2021
Q3
– Sell
-27,025
Closed -$1.7M – 2061
2021
Q2
$1.7M Buy
27,025
+25,292
+1,459% +$935K 0.01% 762
2021
Q1
$47K Buy
+1,733
New +$41.7K ﹤0.01% 1841

Other funds holding ASTH

Acadian Asset Management's ASTH Position: Q3 2026 in Review

Acadian Asset Management reduced its Astrana Health (ASTH) stake by 73% in Q3 2026, selling an estimated $336K and leaving 3,167 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Acadian Asset Management first reported a position in ASTH in Q1 2021 and has held it in 5 quarters since. The position peaked at $1.7M in Q2 2021. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Acadian Asset Management held 3,167 shares of Astrana Health worth $111K as of Q3 2026.
  • Acadian Asset Management sold 8,527 Astrana Health shares in Q3 2026, an estimated $336K.
  • Astrana Health made up ﹤0.01% of Acadian Asset Management's portfolio in Q3 2026, its #1720 holding.
  • Acadian Asset Management first reported a position in Astrana Health in Q1 2021 and has held it in 5 quarters since.
  • Acadian Asset Management's Astrana Health position peaked at $1.7M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Acadian Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.